1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
69A6FBEA30DB182F385257E82005031DD
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/9A6FBEA30DB182F385257E82005031DD!OpenDocument
18
19OpenDocument
203.236.209.138
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Health Outcomes

Document Excerpt: Health Economics & Outcomes Research: Role of Medical Affairs in Health Outcomes Activities

DB Image

ID: MD-472


Features:

9 Info Graphics

13 Data Graphics

80 Metrics

2 Narratives


Pages/Slides: 4


Published: Pre-2018


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click
"Download Free Excerpt".


To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5369 "Health Economics & Outcomes Research: Role of Medical Affairs in Health Outcomes Activities."


Industries Profiled:
Biotech; Pharmaceutical; Medical Device; Manufacturing; Consumer Products; Diagnostic; Health Care; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Amgen; Roche; AstraZeneca; Bayer; Eli Lilly; Merck; Sanofi; Boehringer Ingelheim; Astellas; Baxter Healthcare; Eisai; Upsher-Smith; Insys Therapeutics; Onyx Pharmaceuticals; Lundbeck; Incyte; Jazz Pharmaceuticals; Merz Pharma; UCB Pharma; ProStrakan; Purdue Pharma; MannKind Corporation; Axon Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.